Shin Nippon Biomedical Laboratories, Ltd. 2395

TSE · Japan · Commercial Services

¥1,293.00-30.00 (-2.27%)

Market closed· Oct 2, 2026, 6:30 AM UTC· JPY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Shin Nippon Biomedical Laboratories, Ltd. 2395

TSE · Japan · Commercial Services

¥1,293.00-30.00 (-2.27%)

Market closed· Oct 2, 2026, 6:30 AM UTC· JPY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-9.14% · 6MFull-screen chart

Open ¥1,323.00High ¥1,323.00Low ¥1,293.00Close ¥1,293.00Volume 156.20K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: ¥1,323.00
Day range: ¥1,293.00 – ¥1,323.00
52-week range: ¥1,067.00 – ¥2,005.00
Volume: 156.20K
Market cap: ¥55.08B
P/E (last fiscal year): 11.8
Dividend yield (annualized): 3.78%
Next earnings date: 2026-11-05
Avg. volume (1Y): 243.03K

Performance

1 week

-2.92%

1 month

-2.77%

3 months

+8.93%

6 months

-10.10%

Year to date

-17.38%

1 year

-18.34%

Total return, dividends included.

Company profile

Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Country: Japan
Exchange: TSE
Shares outstanding: 41.63M
Employees: 1,522
ISIN: JP3379950003
Beta: 0.09

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJun 04, 2026

Satsuma Pharmaceuticals Announces Presentation of Two Clinical Program Abstracts at the American Headache Society's 68th Annual Scientific Meeting

Satsuma Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing innovative treatments for people living with migraine, today announced that two abstracts highlighting findings from its clinical development program have been selected for presentation at the American Headache Society's (AHS) 68th Annual Scientific Meeting. The meeting will take place June 4 - 7, 2026, at the Orlando World Center Marriott in Orlando, Florida, with both in-person and virtual attendance options availa

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.